[Analytics Insight] In recent years, the growing crops of startups that leverage artificial intelligence and other advanced technologies have ascended dramatically. As a result, the VC funding and investments in these startups are becoming historically strong year over year. Despite slow VC deals due to the COVID-19 crisis this year, the interest in AI funding is seeing a sustained […]
[Outsourcing-Pharma] The pharmaceutical technology investment fund is partnering with and financing Atomwise, a company that provides AI solutions for drug discovery
[Drug Target Review] According to a new report, artificial intelligence (AI) is vital for the rapid identification of drugs that can be repurposed to combat COVID-19.
[AiThority] Recently, a news report suggested that a team of AI scientists have made a belligerent effort to identify hundreds of new drugs as a potential COVID-19 therapy. COVID-19 is caused by the novel coronavirus, SAR COV-2, whose origins have been speculated to be a wet market in Wuhan in China. AI engineers and pharmaceutical companies are […]
[Crunchbase] Atomwise, which is using artificial intelligence for small molecule drug discovery, received a cash infusion of $123 million in an oversubscribed Series B financing.